Knowing Regs Key as China Gets Tougher on GMP Inspections
This article was originally published in PharmAsia News
Executive Summary
China FDA has significantly beefed up inspections of foreign drug manufacturing sites, underscoring the agency’s increasing assertiveness in regulatory enforcement. Staying out of trouble requires staying on top of local regulatory updates, regulatory experts say.